Topic: Rajiv Shah

Rajiv Shah, President of the Rockefeller Foundation, outlines global immunization targets of 40 percent by year-end and 70 percent by September 2022. Shah warns that failure to reach these goals in developing nations increases the likelihood of new variants due to high viral replication rates. He calls for pharmaceutical companies like Pfizer and Moderna to implement tiered pricing or local manufacturing partnerships to increase access.

Dr. Rajiv Shah, the head of USAID and former official at the Bill and Melinda Gates Foundation, has been appointed to lead the United States' response to the Ebola epidemic in West Africa. Health officials, including CDC Director Tom Frieden, describe the situation as spiraling out of control, while Shah outlines an investment strategy involving 1,000 treatment beds in Liberia. The terminology used by officials, specifically the word "tamp," suggests a strategy of containment rather than total eradication.